Clinical Impact of New Data From AASLD 2019

November 8-12, 2019; Boston, Massachusetts
This downloadable slideset reviews new, clinically relevant data on viral hepatitis and NAFLD/NASH; topics include risk of HCC in patients with viral hepatitis, HBV and HCV treatment, organ transplant from donors with HCV infection, and novel treatments for NAFLD/NASH.
Ira M. Jacobson, MD
Nancy Reau, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 894 KB
Released: December 2, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AbbVie
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.

Related Content

下载由专家编写的免费幻灯片,了解亚太地区关于乙型肝炎环境中 HCC 的考虑的最新信息。

Grace LH Wong, 医学博士 Released: June 18, 2021

B 型肝炎の状況における HCC のリスクに関する、アジア太平洋地域における考慮点について、最新情報を得るために、専門家が作成した無料スライドをダウンロード

Grace LH Wong, MDは Released: June 18, 2021

Download free expert-authored slides to get up-to-date on Asia-Pacific considerations regarding HCC in the setting of hepatitis B.

Grace LH Wong, MD Released: June 10, 2021

Clinical Care Options (CCO) expert Dr Grace LH Wong discusses Asia-Pacific considerations in caring for patients with HBV at risk for HCC

Grace LH Wong, MD Released: June 8, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue